TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$26.84
-0.88 (-3.17%)
Performance
1D
—
1W
—
1M
—
3M
-32.29%
6M
+6.09%
1Y
+27.75%
YTD
-32.09%
Open$27.70
Previous Close$27.72
Day High$27.83
Day Low$26.15
52W High$42.13
52W Low$12.91
Volume—
Avg Volume1.50M
Market Cap2.62B
P/E Ratio—
EPS$-1.08
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.84
Below
SMA 200
$24.79
Above
RSI (14)
40.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+38.4% upside
Current
$26.84
$26.84
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 260.45M | 258.33M | 873.79M |
| Net Income | -359,164,101 | -320,618,618 | 83.63M |
| Profit Margin | -137.9% | -131.0% | 9.6% |
| EBITDA | -318,796,802 | -300,393,733 | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +0.8% | +0.8% | +12.5% |
| Debt/Equity | 6.42 | 6.42 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |